Download
s00103-021-03312-1.pdf 1,72MB
WeightNameValue
1000 Titel
  • Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion
1000 Titelzusatz
  • How do generic quotas work? An analysis using HIV infection as an example
1000 Autor/in
  1. Rüsenberg, Robin |
  2. Baumgarten, Axel |
  3. Mauss, Stefan |
  4. Gradl, Gabriele |
  5. Schulz, Martin |
  6. Bartmeyer, Barbara |
  7. Kollan, Christian |
  8. Schmidt, Daniel |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-04-14
1000 Erschienen in
1000 Quellenangabe
  • 64(5):625-634
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00103-021-03312-1 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087608/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Instruments controlling statutory healthcare medical supply have long been a topic of debate in health policy reform discussions. Over the years, a variety of tools have been developed, most of which are aimed at controlling drug expenditure. The instruments controlling regional prescriptions primarily focus on controlling behavioural patterns of the prescribing physicians. Important to note is the increased use of indication-directed quotas, primarily of drug leads and/or generics/biosimilars. These are now also available in the area of the human immunodeficiency virus (HIV), such as the generic quotas for HIV medications introduced in Bavaria and Berlin in 2020.!##!Objective!#!The aim of this article is to analyse the benefits and limitations of generic quota solutions in HIV care using statutory health insurance drug prescription data and to outline recommendations for action.!##!Results!#!It was observed that the quota potential for generics in the area of patent-free drugs in HIV care has already been largely exhausted. This can be explained by HIV prescribers supporting product exchange on the prescription.!##!Discussion!#!The best-case scenario in terms of regulation has almost been reached. This is due to a suitable set of instruments, including the framework agreement for medical supply as well as prescribing according to guidelines - in conjunction with the Pharmaceuticals Market Reorganisation Act (AMNOG) and reference prices for drugs. Conforming with guidelines and (existing) single-tablet regimens play an integral role in maintaining good quality of care.
1000 Sacherschließung
lokal Arzneimittelversorgung
lokal Ambulante Versorgung
lokal Biosimilar Pharmaceuticals [MeSH]
lokal Ambulatory healthcare
lokal Drugs, Generic/therapeutic use [MeSH]
lokal Drug Prescriptions [MeSH]
lokal Humans [MeSH]
lokal Managed primary care
lokal Originalien und Übersichten
lokal HIV Infections/epidemiology [MeSH]
lokal Secondary data
lokal Gesetzliche Krankenversicherung (GKV)
lokal HIV Infections/drug therapy [MeSH]
lokal Versorgungssteuerung
lokal Germany [MeSH]
lokal Medical supply
lokal Berlin [MeSH]
lokal Sekundärdaten
lokal Statutory health insurance
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UsO8c2VuYmVyZywgUm9iaW4=|https://frl.publisso.de/adhoc/uri/QmF1bWdhcnRlbiwgQXhlbA==|https://frl.publisso.de/adhoc/uri/TWF1c3MsIFN0ZWZhbg==|https://frl.publisso.de/adhoc/uri/R3JhZGwsIEdhYnJpZWxl|https://frl.publisso.de/adhoc/uri/U2NodWx6LCBNYXJ0aW4=|https://frl.publisso.de/adhoc/uri/QmFydG1leWVyLCBCYXJiYXJh|https://frl.publisso.de/adhoc/uri/S29sbGFuLCBDaHJpc3RpYW4=|https://frl.publisso.de/adhoc/uri/U2NobWlkdCwgRGFuaWVs
1000 Hinweis
  • DeepGreen-ID: efae63e31fa9445392bc0c56ca79e94b ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
  1. Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6452078.rdf
1000 Erstellt am 2023-05-12T11:22:44.748+0200
1000 Erstellt von 322
1000 beschreibt frl:6452078
1000 Zuletzt bearbeitet 2023-10-24T08:39:17.764+0200
1000 Objekt bearb. Tue Oct 24 08:39:17 CEST 2023
1000 Vgl. frl:6452078
1000 Oai Id
  1. oai:frl.publisso.de:frl:6452078 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source